Anti-CD100 (Semaphorin-4D)(SEMA4D/933), CF568 conjugate
CAT:
37-BNC680933-500
Size:
500 µL
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Anti-CD100 (Semaphorin-4D)(SEMA4D/933), CF568 conjugate
Description:
CD100 (also known as Semaphorin 4D), is a homodimeric protein comprised of 50 kDa subunits. It is expressed on resting T cells and weakly on other lymphocytes, and its expression is increased on B and T cells after stimulation. CD100 is a cell surface receptor that binds to CD72, Plexin B1 and Plexin B2. It promotes B cell aggregation, cell survival, and cell proliferation.Synonyms:
CD100; Semaphorin-4D; SEMA4DCAS Number:
9007-83-4UNSPSC:
41116161UNSPSC Description:
Primary and secondary antibodies for multiple methodology immunostaining detection applicationGene Name:
SEMA4DGene ID:
10507NCBI Gene ID:
494406UniProt:
Q92854Cellular Locus:
Plasma membraneHost:
MouseSpecies Reactivity:
Human, Non-human monkeyImmunogen:
Human recombinant SEMA4D proteinTarget Antigen:
CD100 | Semaphorin-4DClonality:
MonoclonalIsotype:
IgG1 κClone:
SEMA4D/933Conjugation:
CF568Source:
AnimalField of Research:
Immunology, Neuroscience, Signal transductionPositive Control:
Daudi, Raji, HUT-78, Kg1a, U937, and human lymphocytes. Human tonsils and lymph nodes.Concentration:
0.1 mg/mLBuffer:
PBS, 0.1% BSA, 0.05% azideMolecular Weight:
50 kDa (Monomer)Additionnal Information:
For coating for ELISA, order Ab without BSA|Higher concentration may be required for direct detection using primary antibody conjugates than for indirect detection with secondary antibody|Optimal dilution and staining procedure for a specific application should be determined by user|Recommended starting concentrations for titration are 1-2 ug/mL for most applications, or 1 ug/million cells/100 uL for flow cytometryShipping Conditions:
Room temperatureStorage Conditions:
4°C; Protect from light; Stable at room temperature or 37°C (98°F) for 7 days.Shelf Life:
2 years
DATASHEET Document
View DocumentMSDS Document
View Document